Choonara Yahya E, du Toit Lisa C, Kumar Pradeep, Kondiah Pierre P D, Pillay Viness
a Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences , University of the Witwatersrand, Johannesburg , 7 York Road, Parktown 2193 , South Africa.
Expert Rev Pharmacoecon Outcomes Res. 2016;16(1):23-32. doi: 10.1586/14737167.2016.1138860. Epub 2016 Jan 28.
3D-printing (3DP) is the art and science of printing in a new dimension using 3D printers to transform 3D computer aided designs (CAD) into life-changing products. This includes the design of more effective and patient-friendly pharmaceutical products as well as bio-inspired medical devices. It is poised as the next technology revolution for the pharmaceutical and medical-device industries. After decorous implementation scientists in collaboration with CAD designers have produced innovative medical devices ranging from pharmaceutical tablets to surgical transplants of the human face and skull, spinal implants, prosthetics, human organs and other biomaterials. While 3DP may be cost-efficient, a limitation exists in the availability of 3D printable biomaterials for most applications. In addition, the loss of skilled labor in producing medical devices such as prosthetics and other devices may affect developing economies. This review objectively explores the potential growth and impact of 3DP costs in the medical industry.
3D打印（3DP）是利用3D打印机在新维度进行打印的一门艺术与科学，它能将3D计算机辅助设计（CAD）转化为改变生活的产品。这包括设计更有效且对患者更友好的药品以及受生物启发的医疗设备。它被视为制药和医疗设备行业的下一次技术革命。在经过恰当实施后，科学家与CAD设计师合作，已经制造出了从药片状剂到人脸和头骨的外科移植、脊柱植入物、假肢、人体器官及其他生物材料等各种创新型医疗设备。虽然3D打印可能具有成本效益，但对于大多数应用而言，3D可打印生物材料的可用性存在限制。此外，生产假肢等医疗设备时熟练劳动力的流失可能会影响发展中经济体。本综述客观地探讨了3D打印在医疗行业的潜在增长及成本影响。
